Circulating tumor DNA (ctDNA) variants hold significant promise as cancer biomarkers in liquid biopsies, owing to their minimally invasive testing approach and capacity to capture the comprehensive tu
De-identified mutation data in MAF format and clinical information in CSV format for 'Genomic Profiling Using Vaginal Swab and Plasma in Patients with Endometrial Cancer by Deep Sequencing'
Additional file 3: Supplementary Figure S1. The number and timing of cfDNA analysis in 60 CRC patients. Supplementary Figure S2. Analytical pipeline of the cfDNA test.
